| Tijil Agarwal, | |
|
2065 E South Blvd Ste 201, Montgomery, AL 36116-2460 | |
| (334) 747-7250 | |
| (334) 747-7270 |
| Full Name | Tijil Agarwal |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 11 Years |
| Location | 2065 E South Blvd Ste 201, Montgomery, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104231257 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD.38059 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Russell Medical Center | Alexander city, AL | Hospital |
| Baptist Medical Center East | Montgomery, AL | Hospital |
| Prattville Baptist Hospital | Prattville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Care Authority For Baptist Health, An Affiliate Of Uabhs | 8426076670 | 191 |
News Archive
Experts in the U.S., in an attempt to define the abnormalities in the brains of people with bipolar disorder, have used used functional MRI to measure levels of metabolic activity in different areas of the brain.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Amerinet Inc., a national healthcare group purchasing organization, today continued its leadership in helping to standardize the healthcare supply chain by choosing 1SYNC™ as its data pool for accessing product information in the Global Data Synchronization Network® (GDSN®).
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
› Verified 2 days ago
| Entity Name | Health Care Authority For Baptist Health, An Affiliate Of Uabhs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982653390 PECOS PAC ID: 8426076670 Enrollment ID: O20060220000538 |
News Archive
Experts in the U.S., in an attempt to define the abnormalities in the brains of people with bipolar disorder, have used used functional MRI to measure levels of metabolic activity in different areas of the brain.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Amerinet Inc., a national healthcare group purchasing organization, today continued its leadership in helping to standardize the healthcare supply chain by choosing 1SYNC™ as its data pool for accessing product information in the Global Data Synchronization Network® (GDSN®).
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tijil Agarwal, 301 Brown Springs Rd, Montgomery, AL 36117-7005 Ph: (334) 747-4159 | Tijil Agarwal, 2065 E South Blvd Ste 201, Montgomery, AL 36116-2460 Ph: (334) 747-7250 |
News Archive
Experts in the U.S., in an attempt to define the abnormalities in the brains of people with bipolar disorder, have used used functional MRI to measure levels of metabolic activity in different areas of the brain.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Amerinet Inc., a national healthcare group purchasing organization, today continued its leadership in helping to standardize the healthcare supply chain by choosing 1SYNC™ as its data pool for accessing product information in the Global Data Synchronization Network® (GDSN®).
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
› Verified 2 days ago
Clemmie Palmer Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3090 Woodley Rd Ste A, Montgomery, AL 36116 Phone: 334-280-3230 Fax: 334-280-3272 | |
Dr. Griffin Gibson Ii, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4371 Narrow Lane Rd Ste 205, Montgomery, AL 36116 Phone: 334-747-7780 Fax: 334-747-7790 | |
Dr. Margaret Sellers-bok, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1110 Westmoreland Ave, Montgomery, AL 36106 Phone: 334-263-0909 | |
Reuben C Richardson Iii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 300 Taylor Rd Ste 400, Montgomery, AL 36117 Phone: 334-396-8884 Fax: 334-396-8570 | |
Stephanie Calhoun, LPC Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5906 Carmichael Place, Montgomery, AL 36117 Phone: 334-409-9090 Fax: 334-409-9669 | |
David Dean Hall, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6324 Woodmere Blvd, Montgomery, AL 36117 Phone: 334-272-3889 Fax: 334-272-4089 |